Volume 81, Issue 6 | Drugs

Home
Drugs
Volumes and issues
Volume 81, Issue 6

Drugs

Publishing model:: Hybrid

Submit your manuscript

Search all Drugs articles

Volume 81, Issue 6

April 2021

12 articles in this issue

Neurokinin 1 Receptor Antagonists for Pruritus
Majid Alam
Joerg Buddenkotte
Martin Steinhoff
Leading Article Open access 06 March 2021 Pages: 621 - 634
Fabry Disease: The Current Treatment Landscape
Malte Lenders
Eva Brand
Review Article Open access 15 March 2021 Pages: 635 - 645
Pathophysiology and Management of Variceal Bleeding
Saleh A. Alqahtani
Sunguk Jang
Review Article 12 March 2021 Pages: 647 - 667
Novel Treatments for Mantle Cell Lymphoma: From Targeted Therapies to CAR T Cells
Danielle Wallace
Patrick M. Reagan
Review Article 30 March 2021 Pages: 669 - 684
Prior Treatment with Statins is Associated with Improved Outcomes of Patients with COVID-19: Data from the SEMI-COVID-19 Registry
José David Torres-Peña
Luis M. Pérez-Belmonte
for the SEMI-COVID-19 Network
Original Research Article 29 March 2021 Pages: 685 - 695
Part of 1 collection:

COVID-19
Entrectinib: A Review in NTRK+ Solid Tumours and ROS1+ NSCLC
James E. Frampton
Adis Drug Evaluation Open access 19 April 2021 Pages: 697 - 708
Indacaterol/Glycopyrronium/Mometasone: A Review in Asthma
Hannah A. Blair
Adis Drug Evaluation 19 April 2021 Pages: 709 - 719
Vericiguat: First Approval
Anthony Markham
Sean Duggan
AdisInsight Report 26 March 2021 Pages: 721 - 726
Surufatinib: First Approval
Yahiya Y. Syed
AdisInsight Report 31 March 2021 Pages: 727 - 732
Correction to: Nintedanib: A Review in Fibrotic Interstitial Lung Diseases
Yvette N. Lamb
Correction 13 April 2021 Pages: 733 - 733
Correction to: Secukinumab: A Review in Psoriatic Arthritis
Hannah A. Blair
Correction Open access 15 April 2021 Pages: 735 - 735
Correction to: Ravulizumab: A Review in Atypical Haemolytic Uraemic Syndrome
Yahiya Y. Syed
Correction Open access 19 April 2021 Pages: 737 - 737